Global and Region Pulmonary Drug Delivery Devices/Systems Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.

    North America dominates the dominant drug delivery devices/systems market position. Major local pharmaceutical and medical device manufacturers, advanced medical infrastructure, population ageing, high disposable income and lifestyle changes are all factors driving the overall growth of the North American pharmaceutical drug delivery devices/systems market.

    The report details the trend, potential and market size of Pulmonary Drug Delivery Devices/Systems market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pulmonary Drug Delivery Devices/Systemsmarket, defines the market attractiveness level of Pulmonary Drug Delivery Devices/Systems market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pulmonary Drug Delivery Devices/Systems industry, describes the types of Pulmonary Drug Delivery Devices/Systems market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pulmonary Drug Delivery Devices/Systems market and the development prospects and opportunities of Pulmonary Drug Delivery Devices/Systems industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pulmonary Drug Delivery Devices/Systems market in Chapter 13.

    By Player:

    • Philips Respironics

    • SHL Group

    • Hovione

    • BeyonDevices

    • 3M Health Care

    • GlaxoSmithKline

    • H&T Presspart

    • Bespak

    • PARI Respiratory Equipment

    By Type:

    • Metered Dose Inhalers

    • Dry Powder Inhalers

    • Nebulizers

    • Accessories

    By End-User:

    • Hospitals and Clinics

    • Homecare

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pulmonary Drug Delivery Devices/Systems Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pulmonary Drug Delivery Devices/Systems Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pulmonary Drug Delivery Devices/Systems Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pulmonary Drug Delivery Devices/Systems Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pulmonary Drug Delivery Devices/Systems Market Analysis and Outlook to 2022

    • 7.1 Global Pulmonary Drug Delivery Devices/Systems Consumption (2017-2022)

    • 7.2 United States Pulmonary Drug Delivery Devices/Systems Consumption (2017-2022)

    • 7.3 Europe Pulmonary Drug Delivery Devices/Systems Consumption (2017-2022)

    • 7.4 China Pulmonary Drug Delivery Devices/Systems Consumption (2017-2022)

    • 7.5 Japan Pulmonary Drug Delivery Devices/Systems Consumption (2017-2022)

    • 7.6 India Pulmonary Drug Delivery Devices/Systems Consumption (2017-2022)

    • 7.7 South Korea Pulmonary Drug Delivery Devices/Systems Consumption (2017-2022)

    8 Region and Country-wise Pulmonary Drug Delivery Devices/Systems Market Analysis and Outlook to 2028

    • 8.1 Global Pulmonary Drug Delivery Devices/Systems Consumption Forecast (2022-2028)

    • 8.2 United States Pulmonary Drug Delivery Devices/Systems Consumption Forecast (2022-2028)

    • 8.3 Europe Pulmonary Drug Delivery Devices/Systems Consumption Forecast (2022-2028)

    • 8.4 China Pulmonary Drug Delivery Devices/Systems Consumption Forecast (2022-2028)

    • 8.5 Japan Pulmonary Drug Delivery Devices/Systems Consumption Forecast (2022-2028)

    • 8.6 India Pulmonary Drug Delivery Devices/Systems Consumption Forecast (2022-2028)

    • 8.7 South Korea Pulmonary Drug Delivery Devices/Systems Consumption Forecast (2022-2028)

    9 Global Pulmonary Drug Delivery Devices/Systems Market Outlook by Types and Applications to 2022

    • 9.1 Global Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Metered Dose Inhalers Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dry Powder Inhalers Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Nebulizers Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Accessories Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Homecare Consumption and Growth Rate (2017-2022)

    10 Global Pulmonary Drug Delivery Devices/Systems Market Outlook by Types and Applications to 2028

    • 10.1 Global Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Metered Dose Inhalers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Dry Powder Inhalers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Accessories Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pulmonary Drug Delivery Devices/Systems Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pulmonary Drug Delivery Devices/Systems Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pulmonary Drug Delivery Devices/Systems Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pulmonary Drug Delivery Devices/Systems Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pulmonary Drug Delivery Devices/Systems Market Competitive Analysis

    • 14.1 Philips Respironics

      • 14.1.1 Philips Respironics Company Details

      • 14.1.2 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.2 SHL Group

      • 14.2.1 SHL Group Company Details

      • 14.2.2 SHL Group Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 SHL Group Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.3 Hovione

      • 14.3.1 Hovione Company Details

      • 14.3.2 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Hovione Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.4 BeyonDevices

      • 14.4.1 BeyonDevices Company Details

      • 14.4.2 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.5 3M Health Care

      • 14.5.1 3M Health Care Company Details

      • 14.5.2 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.6 GlaxoSmithKline

      • 14.6.1 GlaxoSmithKline Company Details

      • 14.6.2 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.7 H&T Presspart

      • 14.7.1 H&T Presspart Company Details

      • 14.7.2 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.8 Bespak

      • 14.8.1 Bespak Company Details

      • 14.8.2 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bespak Pulmonary Drug Delivery Devices/Systems Product and Service

    • 14.9 PARI Respiratory Equipment

      • 14.9.1 PARI Respiratory Equipment Company Details

      • 14.9.2 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pulmonary Drug Delivery Devices/Systems

    • Figure Pulmonary Drug Delivery Devices/Systems Picture

    • Table Global Pulmonary Drug Delivery Devices/Systems Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pulmonary Drug Delivery Devices/Systems Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pulmonary Drug Delivery Devices/Systems Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pulmonary Drug Delivery Devices/Systems Consumption by Country (2017-2022)

    • Figure United States Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate (2017-2022)

    • Table Europe Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate (2017-2022)

    • Figure China Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate (2017-2022)

    • Figure Japan Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate (2017-2022)

    • Figure India Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pulmonary Drug Delivery Devices/Systems Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonary Drug Delivery Devices/Systems Consumption Forecast by Country (2022-2028)

    • Figure United States Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pulmonary Drug Delivery Devices/Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metered Dose Inhalers Consumption and Growth Rate (2017-2022)

    • Figure Global Dry Powder Inhalers Consumption and Growth Rate (2017-2022)

    • Figure Global Nebulizers Consumption and Growth Rate (2017-2022)

    • Figure Global Accessories Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Metered Dose Inhalers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dry Powder Inhalers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Accessories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pulmonary Drug Delivery Devices/Systems Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pulmonary Drug Delivery Devices/Systems Export by Region (Top 5 Countries) (2017-2028)

    • Table Philips Respironics (Foundation Year, Company Profile and etc.)

    • Table Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Philips Respironics Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table SHL Group (Foundation Year, Company Profile and etc.)

    • Table SHL Group Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table SHL Group Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table Hovione (Foundation Year, Company Profile and etc.)

    • Table Hovione Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hovione Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table BeyonDevices (Foundation Year, Company Profile and etc.)

    • Table BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table BeyonDevices Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table 3M Health Care (Foundation Year, Company Profile and etc.)

    • Table 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Health Care Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table H&T Presspart (Foundation Year, Company Profile and etc.)

    • Table H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table H&T Presspart Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table Bespak (Foundation Year, Company Profile and etc.)

    • Table Bespak Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bespak Pulmonary Drug Delivery Devices/Systems Product and Service

    • Table PARI Respiratory Equipment (Foundation Year, Company Profile and etc.)

    • Table PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Price, Value and Gross Profit (2017-2022)

    • Table PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.